- Trials with a EudraCT protocol (92)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
92 result(s) found for: PSMA.
Displaying page 1 of 5.
| EudraCT Number: 2021-000456-19 | Sponsor Protocol Number: BC-09501 | Start Date*: 2021-11-17 |
| Sponsor Name:University Hospital Ghent | ||
| Full Title: Use of 18F-PSMA-11 PET for detection of lesions in iodine refractory thyroid cancers | ||
| Medical condition: Patients with a iodine refractory thyroid carcinoma, who received an 18F -FDG PET/CT scan in routine clinical practice. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2019-003346-32 | Sponsor Protocol Number: ET-19-194 | Start Date*: 2020-04-07 |
| Sponsor Name:Centre Léon Bérard | ||
| Full Title: PREFAcE : Interest of PET-PSMA imaging potentiated by androgen blockade in patients with biological relapse or persistent biological disease of a localized prostatic adenocarcinoma after initial tr... | ||
| Medical condition: Patient with Prostate Adenocarcinoma in biological relapse or in biological recurrent disease | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male | |
| Trial protocol: FR (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2015-005046-55 | Sponsor Protocol Number: 20151104 | Start Date*: 2016-08-23 |
| Sponsor Name:Umeå University Hospital | ||
| Full Title: Evaluation of [68Ga]PSMA PET/MRI in intermediate and high risk prostate cancer – a comparison with mpMRI, [11C]ACE PET/CT and histopathological validation | ||
| Medical condition: Medium and high risk prostate cancer | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male | |
| Trial protocol: SE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2018-004853-26 | Sponsor Protocol Number: T315/2018 | Start Date*: 2019-03-25 | ||||||||||||||||
| Sponsor Name:Turku University Hospital | ||||||||||||||||||
| Full Title: The effect of androgen deprivation therapy on the expression of prostate specific membrane antigen (PSMA) in treatment naive metastatic prostate cancer | ||||||||||||||||||
| Medical condition: Metastatic prostate cancer | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male | |||||||||||||||||
| Trial protocol: FI (Trial now transitioned) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2015-004425-13 | Sponsor Protocol Number: PP01 | Start Date*: 2016-01-22 | |||||||||||
| Sponsor Name:Skåne University Hospital, Department of Oncology | |||||||||||||
| Full Title: Prospective evaluation of 68-Ga-PSMA-PET and early PSA kinetics during salvage radiotherapy for personalizing the management of men with relapse of prostate cancer after radical prostatectomy. | |||||||||||||
| Medical condition: Patients with prostate cancer, with a PSA recurrence of ˃ 0.2 ng/ml after prostatectomy, and who are going to receive radiotherapy to the prostate bed. | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male | ||||||||||||
| Trial protocol: SE (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2022-003713-11 | Sponsor Protocol Number: 1938/2022 | Start Date*: 2023-11-17 |
| Sponsor Name:Medical University of Vienna [...] | ||
| Full Title: [177Lu]Lu-PSMAI&T radioligand therapy (PSMA-RLT) for patients with prostate cancer and biochemical but not radio-morphological local recurrence after primary therapy with curative intent: A Prospec... | ||
| Medical condition: Prostate cancer | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male | |
| Trial protocol: AT (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2022-004115-92 | Sponsor Protocol Number: 1944/2022 | Start Date*: 2023-11-14 |
| Sponsor Name:Medical University of Vienna | ||
| Full Title: Neoadjuvant [177Lu]Lu-PSMAI&T radioligand therapy (PSMA-RLT) for patients with oligometastatic prostate cancer diagnosed using [68Ga]Ga-PSMA-11 PET imaging followed by radical prostatectomy: A Pros... | ||
| Medical condition: Prostate Cancer | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male | |
| Trial protocol: AT (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-003323-42 | Sponsor Protocol Number: 29BRC20.0203 | Start Date*: 2021-03-01 | |||||||||||
| Sponsor Name:CHRU de Brest | |||||||||||||
| Full Title: Diagnostic Performance of prostate specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) imaging for Pre-operative lymph Node assessment in intermediate and hig... | |||||||||||||
| Medical condition: Prostate cancer | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male | ||||||||||||
| Trial protocol: FR (Trial now transitioned) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2017-002093-40 | Sponsor Protocol Number: 104902 | Start Date*: 2017-08-30 |
| Sponsor Name:Radboudumc | ||
| Full Title: 68Ga-PSMA-PET/CT imaging for locally advanced, recurrent and metastatic adenoid cystic carcinoma or salivary duct carcinoma | ||
| Medical condition: Patients with locally advanced, recurrent or metastatic adenoid cystic carcinoma or salivary duct carcinoma | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2022-003788-13 | Sponsor Protocol Number: 1013 | Start Date*: 2023-09-21 |
| Sponsor Name:Heikki Minn | ||
| Full Title: Molecular theranostics for metastatic prostate cancer: PSMA, FAPI, or both? | ||
| Medical condition: Metastatic prostate cancer | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male | |
| Trial protocol: FI (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2019-003177-26 | Sponsor Protocol Number: RT2019-13 | Start Date*: 2020-02-05 |
| Sponsor Name:UMCG | ||
| Full Title: Androgen Deprivation therapy for Oligo-recurrent Prostate cancer in addition to radioTherapy | ||
| Medical condition: Patients with biochemical recurrence after primary treatment of prostate cancer presenting with ≤4 metastases | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male | |
| Trial protocol: NL (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2019-002957-46 | Sponsor Protocol Number: 56021927PCR3015 | Start Date*: 2020-05-13 | |||||||||||
| Sponsor Name:Janssen-Cilag International NV | |||||||||||||
| Full Title: A Randomized, Controlled, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients with Hormone-Sensitive Pr... | |||||||||||||
| Medical condition: High risk recurrent prostate cancer previously treated with radical prostatectomy | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male | ||||||||||||
| Trial protocol: SE (Trial now transitioned) CZ (Trial now transitioned) DK (Trial now transitioned) PL (Trial now transitioned) ES (Ongoing) AT (Trial now transitioned) PT (Trial now transitioned) BE (Trial now transitioned) SK (Trial now transitioned) IT (Trial now transitioned) HU (Trial now transitioned) FI (Trial now transitioned) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2020-004991-16 | Sponsor Protocol Number: tba | Start Date*: 2022-09-28 |
| Sponsor Name: | ||
| Full Title: 177Lu-PSMA RADIOLIGAND THERAPY IN PATIENTS WITH LYMPH NODE METASTATIC HORMONE-SENSITIVE PROSTATE CANCER UNDERGOING ROBOT-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY AND EXTENDED PELVIC LYMPH NODE D... | ||
| Medical condition: prostate cancer, eligible for radical prostatectomy and extended pelvic lymph node dissection, with 1-3 pelvic nodal metastases on preoperative PSMA PET | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2021-006810-35 | Sponsor Protocol Number: Glioma_Theranostics | Start Date*: 2022-11-02 |
| Sponsor Name:Norwegian University of Science and Technology | ||
| Full Title: 68Ga/177Lu-PSMA theranostics in recurrent grade 3 and grade 4 glioma | ||
| Medical condition: Patients with confirmed recurrent grade 3 and grade 4 glioma | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NO (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2015-005016-15 | Sponsor Protocol Number: 55589 | Start Date*: 2016-06-15 |
| Sponsor Name:Radboudumc | ||
| Full Title: Accuracy of lymph node imaging in prostate cancer: A prospective cohort study to determine the concordance between two imaging modalities, “Combidex” magnetic resonance imaging (Nano MRI) and 68Ga-... | ||
| Medical condition: Detection of lymph node metastasis in prostate cancer. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male | |
| Trial protocol: NL (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2019-003284-21 | Sponsor Protocol Number: 71151 | Start Date*: 2020-01-13 |
| Sponsor Name:Radboudumc | ||
| Full Title: Radio guided lymph node dissection in oligo metastatic prostate cancer patients; a feasibility study | ||
| Medical condition: Patients diagnosed with prostate cancer upon prostate biopsy, who are suspected of having lymph node involvement based upon PSMA-PET/CT. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-005010-59 | Sponsor Protocol Number: THERAG0001 | Start Date*: 2018-05-17 |
| Sponsor Name:Theragnostics Ltd | ||
| Full Title: A Phase II, Open-label Study to Assess Safety and Clinical Utility of 68Ga-THP-PSMA PET/CT in Patients with High Risk Primary Prostate Cancer or Biochemical Recurrence after Radical treatment | ||
| Medical condition: High Risk Primary Prostate Cancer or Biochemical Recurrence after Radical treatment | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male | |
| Trial protocol: GB (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2021-002055-12 | Sponsor Protocol Number: NL76042.091.21 | Start Date*: 2021-08-26 |
| Sponsor Name:Canisius Wilhelmina Hospital | ||
| Full Title: Multi-institutional Evaluation of the Cost-effectiveness of PSMA-PET/CT for the Detection of Pelvic Lymph Node Invasion in Newly Diagnosed Prostate Cancer Patients | ||
| Medical condition: Patients with newly-diagnosed PCa, without evidence of distant metastasis (any T, M0), who are candidates for treatment with radical prostatectomy and ePLND based on a nomogramcalculated risk of LN... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male | |
| Trial protocol: NL (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2022-000066-18 | Sponsor Protocol Number: S65935 | Start Date*: 2022-03-23 |
| Sponsor Name:Universitaire Ziekenhuizen Leuven | ||
| Full Title: Metastasis-directed therapy for oligorecurrent prostate cancer: a randomized phase III trial | ||
| Medical condition: Oligorecurrent hormone-sensitive prostate cancer patients | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male | |
| Trial protocol: BE (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2021-000184-78 | Sponsor Protocol Number: 2020110470 | Start Date*: 2021-06-21 | |||||||||||
| Sponsor Name:Odense University Hospital | |||||||||||||
| Full Title: Recurrent and Metastatic Prostate Cancer: Impact of 18F-PSMA-1007 PET/CT on clinical decision making and response monitoring | |||||||||||||
| Medical condition: Metastatic Prostate Cancer | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male | ||||||||||||
| Trial protocol: DK (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
